Cargando…

Proactive palliative care for patients with COPD (PROLONG): a pragmatic cluster controlled trial

BACKGROUND AND AIM: Patients with advanced chronic obstructive pulmonary disease (COPD) have poor quality of life. The aim of this study was to assess the effects of proactive palliative care on the well-being of these patients. TRIAL REGISTRATION: This trial is registered with the Netherlands Trial...

Descripción completa

Detalles Bibliográficos
Autores principales: Duenk, RG, Verhagen, C, Bronkhorst, EM, van Mierlo, PJWB, Broeders, MEAC, Collard, SM, Dekhuijzen, PNR, Vissers, KCP, Heijdra, Y, Engels, Y
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628666/
https://www.ncbi.nlm.nih.gov/pubmed/29033560
http://dx.doi.org/10.2147/COPD.S141974
_version_ 1783268924284993536
author Duenk, RG
Verhagen, C
Bronkhorst, EM
van Mierlo, PJWB
Broeders, MEAC
Collard, SM
Dekhuijzen, PNR
Vissers, KCP
Heijdra, Y
Engels, Y
author_facet Duenk, RG
Verhagen, C
Bronkhorst, EM
van Mierlo, PJWB
Broeders, MEAC
Collard, SM
Dekhuijzen, PNR
Vissers, KCP
Heijdra, Y
Engels, Y
author_sort Duenk, RG
collection PubMed
description BACKGROUND AND AIM: Patients with advanced chronic obstructive pulmonary disease (COPD) have poor quality of life. The aim of this study was to assess the effects of proactive palliative care on the well-being of these patients. TRIAL REGISTRATION: This trial is registered with the Netherlands Trial Register, NTR4037. PATIENTS AND METHODS: A pragmatic cluster controlled trial (quasi-experimental design) was performed with hospitals as cluster (three intervention and three control) and a pretrial assessment was performed. Hospitals were selected for the intervention group based on the presence of a specialized palliative care team (SPCT). To control for confounders, a pretrial assessment was performed in which hospitals were compared on baseline characteristics. Patients with COPD with poor prognosis were recruited during hospitalization for acute exacerbation. All patients received usual care while patients in the intervention group received additional proactive palliative care in monthly meetings with an SPCT. Our primary outcome was change in quality of life score after 3 months, which was measured using the St George Respiratory Questionnaire (SGRQ). Secondary outcomes were, among others, quality of life at 6, 9 and 12 months; readmissions: survival; and having made advance care planning (ACP) choices. All analyses were performed following the principle of intention to treat. RESULTS: During the year 2014, 228 patients (90 intervention and 138 control) were recruited and at 3 months, 163 patients (67 intervention and 96 control) completed the SGRQ. There was no significant difference in change scores of the SGRQ total at 3 months between groups (−0.79 [95% CI, −4.61 to 3.34], p=0.70). However, patients who received proactive palliative care experienced less impact of their COPD (SGRQ impact subscale) at 6 months (−6.22 [−11.73 to −0.71], p=0.04) and had more often made ACP choices (adjusted odds ratio 3.26 [1.49–7.14], p=0.003). Other secondary outcomes were not significantly different. CONCLUSION: Proactive palliative care did not improve the overall quality of life of patients with COPD. However, patients more often made ACP choices which may lead to better quality of care toward the end of life.
format Online
Article
Text
id pubmed-5628666
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-56286662017-10-13 Proactive palliative care for patients with COPD (PROLONG): a pragmatic cluster controlled trial Duenk, RG Verhagen, C Bronkhorst, EM van Mierlo, PJWB Broeders, MEAC Collard, SM Dekhuijzen, PNR Vissers, KCP Heijdra, Y Engels, Y Int J Chron Obstruct Pulmon Dis Original Research BACKGROUND AND AIM: Patients with advanced chronic obstructive pulmonary disease (COPD) have poor quality of life. The aim of this study was to assess the effects of proactive palliative care on the well-being of these patients. TRIAL REGISTRATION: This trial is registered with the Netherlands Trial Register, NTR4037. PATIENTS AND METHODS: A pragmatic cluster controlled trial (quasi-experimental design) was performed with hospitals as cluster (three intervention and three control) and a pretrial assessment was performed. Hospitals were selected for the intervention group based on the presence of a specialized palliative care team (SPCT). To control for confounders, a pretrial assessment was performed in which hospitals were compared on baseline characteristics. Patients with COPD with poor prognosis were recruited during hospitalization for acute exacerbation. All patients received usual care while patients in the intervention group received additional proactive palliative care in monthly meetings with an SPCT. Our primary outcome was change in quality of life score after 3 months, which was measured using the St George Respiratory Questionnaire (SGRQ). Secondary outcomes were, among others, quality of life at 6, 9 and 12 months; readmissions: survival; and having made advance care planning (ACP) choices. All analyses were performed following the principle of intention to treat. RESULTS: During the year 2014, 228 patients (90 intervention and 138 control) were recruited and at 3 months, 163 patients (67 intervention and 96 control) completed the SGRQ. There was no significant difference in change scores of the SGRQ total at 3 months between groups (−0.79 [95% CI, −4.61 to 3.34], p=0.70). However, patients who received proactive palliative care experienced less impact of their COPD (SGRQ impact subscale) at 6 months (−6.22 [−11.73 to −0.71], p=0.04) and had more often made ACP choices (adjusted odds ratio 3.26 [1.49–7.14], p=0.003). Other secondary outcomes were not significantly different. CONCLUSION: Proactive palliative care did not improve the overall quality of life of patients with COPD. However, patients more often made ACP choices which may lead to better quality of care toward the end of life. Dove Medical Press 2017-09-28 /pmc/articles/PMC5628666/ /pubmed/29033560 http://dx.doi.org/10.2147/COPD.S141974 Text en © 2017 Duenk et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Duenk, RG
Verhagen, C
Bronkhorst, EM
van Mierlo, PJWB
Broeders, MEAC
Collard, SM
Dekhuijzen, PNR
Vissers, KCP
Heijdra, Y
Engels, Y
Proactive palliative care for patients with COPD (PROLONG): a pragmatic cluster controlled trial
title Proactive palliative care for patients with COPD (PROLONG): a pragmatic cluster controlled trial
title_full Proactive palliative care for patients with COPD (PROLONG): a pragmatic cluster controlled trial
title_fullStr Proactive palliative care for patients with COPD (PROLONG): a pragmatic cluster controlled trial
title_full_unstemmed Proactive palliative care for patients with COPD (PROLONG): a pragmatic cluster controlled trial
title_short Proactive palliative care for patients with COPD (PROLONG): a pragmatic cluster controlled trial
title_sort proactive palliative care for patients with copd (prolong): a pragmatic cluster controlled trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5628666/
https://www.ncbi.nlm.nih.gov/pubmed/29033560
http://dx.doi.org/10.2147/COPD.S141974
work_keys_str_mv AT duenkrg proactivepalliativecareforpatientswithcopdprolongapragmaticclustercontrolledtrial
AT verhagenc proactivepalliativecareforpatientswithcopdprolongapragmaticclustercontrolledtrial
AT bronkhorstem proactivepalliativecareforpatientswithcopdprolongapragmaticclustercontrolledtrial
AT vanmierlopjwb proactivepalliativecareforpatientswithcopdprolongapragmaticclustercontrolledtrial
AT broedersmeac proactivepalliativecareforpatientswithcopdprolongapragmaticclustercontrolledtrial
AT collardsm proactivepalliativecareforpatientswithcopdprolongapragmaticclustercontrolledtrial
AT dekhuijzenpnr proactivepalliativecareforpatientswithcopdprolongapragmaticclustercontrolledtrial
AT visserskcp proactivepalliativecareforpatientswithcopdprolongapragmaticclustercontrolledtrial
AT heijdray proactivepalliativecareforpatientswithcopdprolongapragmaticclustercontrolledtrial
AT engelsy proactivepalliativecareforpatientswithcopdprolongapragmaticclustercontrolledtrial